Postmortem Distribution of Tapentadol and N-Desmethyltapentadol

Autor: Scott J. Larson, Ciena Bayard, Joseph Pestaner, Sunil K. Prashar, Marie Pierre-Louis, Lucas W. Zarwell
Rok vydání: 2012
Předmět:
Zdroj: Journal of Analytical Toxicology. 36:440-443
ISSN: 1945-2403
0146-4760
DOI: 10.1093/jat/bks041
Popis: The following tests were completed for the detection of drugs in the subject’s femoral blood: volatiles, immunoassay [Orasure, Bethlehem, PA: amphetamines, barbiturates, benzodiazepines, cocaine, methadone, phencyclidine (PCP), opiates, methamphetamine, tetrahydrocannabinol (THC)], full scan gas chromatography– mass spectrometry with nitrogen phosphorus detection (GC –MS-NPD) base screen, and liquid chromatography–tandem mass spectrometry (LC – MS-MS) directed multiple reaction monitoring (MRM) screen (180 drugs). The immunoassay produced a positive benzodiazepine response, which was confirmed in both the base screen and with GC – MS quantitation. An unknown peak with no library match was also found in the base screen (m/z 58, 221, 107). Upon receiving these preliminary results and following discussions with the medical examiner, further interviews with the family revealed that the decedent “sometimes took a pill to energize self” from an unmarked pill bottle. Using collegial assistance it was determined that this peak was may be the compound tapentadol. The decedent had no pharmaceutical prescriptions for tapentadol or diazepam, but over the course of the previous month had received prescriptions for enoxaparin, albuterol, ipratropium, petrolat, ceftriaxone, pantoprazole, furosemide, gentamicin, advair, senna and Colace. Our laboratory would not expect to detect any of these drugs at therapeutic concentrations, with the exception of albuterol. None of these were detected. Tapentadol was confirmed by LC–MS-MS.
Databáze: OpenAIRE